Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

MARKET COMMENT: Shell Overtakes BP Amid Mixed London Trading

30th Apr 2014 09:47

LONDON (Alliance News) - UK stocks trade mixed Wednesday, as investors await a raft of releases from the US and after the preliminary reading of eurozone consumer price inflation accelerated from a more than four-year low, but still missed forecasts. By mid-morning, the FTSE 100 is marginal Read More

CORRECT: MARKET COMMENT: GlaxoSmithKline Results Due At 1100 GMT

30th Apr 2014 07:32

(An item published at 0745 BST misstated the time GlaxoSmithKline is due to release its first-quarter results. The correct time follows.) Pharmaceutical giant GlaxoSmithKline is due to publish its first quarter results at 1100 GMT. By James Kemp; [email protected]; @jamespkem Read More

MARKET COMMENT: UK Stocks Set To Open Flat To Slightly Lower

30th Apr 2014 06:45

LONDON (Alliance News) - UK equities are set to open flat to slightly lower Wednesday, following some strong gains posted on Tuesday, as investors take their positions ahead of important macro economic releases from Europe and the US. Meanwhile, market participants in London face another da Read More

MARKET COMMENT: FTSE 100 Closes At Seven-Week High

29th Apr 2014 16:27

LONDON (Alliance News) - The FTSE 100 closed higher for the second day in a row Tuesday, ending the day at its highest closing level since March 6, buoyed in part by a strong performance by oil major BP and drugs company Shire.<br /><br />Meanwhile, it was a volatile day for the pound. Sterlin Read More

Vectura Triggers Final Milestone Payment Under 2010 Glaxo Licensing Deal

29th Apr 2014 11:16

LONDON (Alliance News) - Respiratory treatment development company Vectura Group PLC Tuesday said it has triggered a GBP2 million milestone payment from GlaxoSmithKline PLC, a day after the drugs giant launched its chronic obstructive pulmonary disease treatment Anoro Ellipta in the US. Gla Read More

UK Earnings, Trading Statements Calendar - Week Ahead

29th Apr 2014 05:17

Read More

Glaxo Granted EU Marketing Authorisation For COPD Treatment Incruse

28th Apr 2014 15:18

LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that its compound Incruse had been granted marketing authorisation by the European Commission as a treatment for chronic obstructive pulmonary disease. Glaxo expects the product to launch in Europe by the end of 2014. Incruse is Read More

UK Earnings, Trading Statements Calendar - Week Ahead

28th Apr 2014 15:13

Read More

Glaxo And Theravance Launch COPD Drug Anoro Ellipta At US Pharmacies

28th Apr 2014 12:28

LONDON (Alliance News) - GlaxoSmithKline PLC and Theravance Inc Monday launched their chronic obstructive pulmonary disease treatment Anoro Ellipta at retail pharmacies in the US. Under the terms of its agreement with Glaxo, Theravance has agreed to make a milestone payment of USD30 million Read More

UK MIDDAY BRIEFING: Healthcare Stocks Lifted By Chary AstraZeneca

28th Apr 2014 11:35

LONDON (Alliance News) -<strong> AstraZeneca</strong> has led the FTSE 100 all Monday morning after US drugs giant Pfizer confirmed that it has now twice approached British peer with a takeover proposal.<br /><br />Pzifer said it is considering its options after being rebuffed for a second tim Read More

UK WINNERS & LOSERS: AstraZeneca Leads Risers; BG Group Falls

28th Apr 2014 10:48

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.<br />-------<br /><strong>FTSE 100 - WINNERS</strong><br />-------<br /><strong>AstraZeneca</strong>, up 15%. US drugs giant Pfizer Inc has confirmed that it has now t Read More

MARKET COMMENT: Pharmaceutical Merger Talk Leads FTSE 100 Higher

28th Apr 2014 09:53

LONDON (Alliance News) - UK stocks indices are mixed Monday, with little in the economic calendar to provide direction and developments in Ukraine weighing on sentiment, but with a significant shot-in-the-arm provided by continued merger and and acquisition activity in the pharmaceutical sector.< Read More

UK Earnings, Trading Statements Calendar - Week Ahead

28th Apr 2014 05:30

Read More

UK Earnings, Trading Statements Calendar - Week Ahead

25th Apr 2014 15:39

Read More

Lombard Medical To Leave AIM Following USD55 Million NASDAQ IPO

25th Apr 2014 09:40

LONDON (Alliance News) - Lombard Medical Technology PLC Friday announced it has suspended trading on AIM, after it raised USD55 million in its initial public offering on the NASDAQ market in New York. The company's shares will be cancelled from the AIM market next Wednesday, when it will b Read More

PRESS: Botox Maker Allergan Made Takeover Approach To Shire - Reuters

25th Apr 2014 09:30

LONDON (Alliance News) - Botox maker Allergan Inc approached Ireland-based pharmaceutical firm Shire PLC about a possible takeover in recent months, but was rebuffed, Reuters reported late Thursday citing people familiar with the matter. The approach did not progress to serious discussions Read More

UK Earnings, Trading Statements Calendar - Week Ahead

25th Apr 2014 05:17

Read More

UK Earnings, Trading Statements Calendar - Week Ahead

24th Apr 2014 15:51

Read More

UK MIDDAY BRIEFING: AstraZeneca Maintains Guidance Despite Profit Hit

24th Apr 2014 12:16

LONDON (Alliance News) - <strong>AstraZeneca</strong> shares jumped Thursday after the pharmaceutical giant maintained its full-year guidance for 2014, even as its pretax profit dropped in the first quarter to end-March, hit by write-downs on the sale of its Alderley Park site and its acquisit Read More

UK Earnings, Trading Statements Calendar - Week Ahead

24th Apr 2014 05:14

Read More

FTSE 100 Latest
Value8,735.60
Change16.85